Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma

BACKGROUND: The utility of O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation status as a prognostic marker in patients with glioblastoma (GBM) has been established. However, the number of CpG sites that must be methylated to cause transcriptional silencing remains unclear, an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epigenetics
Autors principals: Hanihara, Mitsuto, Miyake, Kunio, Watanabe, Atsushi, Yamada, Yuriko, Oishi, Naoki, Kawataki, Tomoyuki, Inukai, Takeshi, Kondo, Tetsuo, Kinouchi, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672949/
https://ncbi.nlm.nih.gov/pubmed/33203454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-020-00968-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars